发明授权
- 专利标题： Glucagon analogues
-
申请号： US14516216申请日： 2014-10-16
-
公开(公告)号： US09988429B2公开(公告)日： 2018-06-05
- 发明人: Ditte Riber , Jakob Lind Tolborg , Dieter Wolfgang Hamprecht
- 申请人： Zealand Pharma A/S , Boehringer Ingelheim International GmbH
- 申请人地址： DK Glostrup
- 专利权人： Zealand Pharma A/S
- 当前专利权人： Zealand Pharma A/S
- 当前专利权人地址： DK Glostrup
- 代理机构： Clark & Elbing LLP
- 主分类号： C07K14/605
- IPC分类号： C07K14/605 ; A61K38/00
摘要：
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
公开/授权文献
- US20150111817A1 GLUCAGON ANALOGUES 公开/授权日：2015-04-23
信息查询
